(Q46684476)

English

Effects of ICL670 (deferasirox) on cardiac iron concentrations

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16139648

title

Effects of ICL670 (deferasirox) on cardiac iron concentrations (English)

1 reference

stated in

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16139648

author

George J Kontoghiorghes

series ordinal

1

object named as

George J Kontoghiorghes

1 reference

stated in

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16139648

language of work or name

English

0 references

publication date

1 September 2005

1 reference

stated in

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16139648

published in

The Lancet

1 reference

stated in

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16139648

volume

366

1 reference

stated in

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16139648

issue

9488

1 reference

stated in

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16139648

page(s)

804

1 reference

stated in

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16139648

cites work

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967205-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic use of deferiprone (L1) and magnetic resonance imaging T2* or T2 for preventing heart disease in thalassaemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967205-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967205-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967205-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0140-6736(05)67205-4

1 reference

stated in

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16139648

PubMed ID

16139648

1 reference

stated in

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16139648

(Q46684476)

Effects of ICL670 (deferasirox) on cardiac iron concentrations

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)